FirstWave Bio, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From FirstWave Bio, Inc.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.
Call it digital health, mobile health, connected health, or information-enabled care delivery, in health care there is a new convergence of wireless sensing technologies, tablets, personalized medicine, cloud-based computing, and novel business models, and it all goes under the rubric of health care efficiency. Going forward, the latter will be the driver of Aberdare Venture Capital’s investment strategy, and in April, the VC made an announcement that signaled its whole-hearted commitment to the space.
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
Medication adherence is a big problem, and recent studies are bringing the actual costs and causes into sharper focus. At the same time, health care reforms such as electronic health records and prescriptions, as well as new incentives from the US government, have encouraged investors to tackle solutions to the problem. Questions remain about the impact of these reforms, but the companies profiled in this issue, HealthPrize Technologies, PillJogger, RxAnte and SentiCare, see an evolving climate in which their medication adherence technology solutions can turn into profitable businesses.